ACM
Aquilo Capital Management Portfolio holdings
AUM
$37.1M
This Quarter Return
-9.36%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$37.1M
AUM Growth
+$37.1M
(-36%)
Cap. Flow
-$8.76M
Cap. Flow
% of AUM
-23.61%
Top 10 Holdings %
Top 10 Hldgs %
93.85%
Holding
15
New
1
Increased
3
Reduced
7
Closed
2
Top Buys
| 1 |
Zymeworks
ZYME
|
$1.01M |
| 2 |
Precision BioSciences
DTIL
|
$905K |
| 3 |
Protagonist Therapeutics
PTGX
|
$247K |
| 4 |
Arvinas
ARVN
|
$225K |
Top Sells
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$4.04M |
| 2 |
SLN
Silence Therapeutics
SLN
|
$2.53M |
| 3 |
Arrowhead Research
ARWR
|
$2.01M |
| 4 |
Kymera Therapeutics
KYMR
|
$1.23M |
| 5 |
Regenxbio
RGNX
|
$536K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
1
DELISTED
Blueprint Medicines
BPMC
| $7.43M | 13.32% | 83,926 -45,674 | -35% | -$4.04M |
|
|
2
Arrowhead Research
ARWR
$3.05B
| $7.01M | 12.57% | 550,130 -157,459 | -22% | -$2.01M |
|
|
3
Protagonist Therapeutics
PTGX
$3.67B
| $3.95M | 7.08% | 81,692 +5,100 | +7% | +$247K |
|
|
4
Kymera Therapeutics
KYMR
$2.95B
| $3.79M | 6.8% | 138,521 -45,000 | -25% | -$1.23M |
|
|
5
Precision BioSciences
DTIL
$57.8M
| $3.46M | 6.21% | 726,149 +189,773 | +35% | +$905K |
|
|
6
Arvinas
ARVN
$568M
| $2.53M | 4.54% | 360,766 +32,000 | +10% | +$225K |
|
|
7
Regenxbio
RGNX
$451M
| $1.94M | 3.48% | 271,302 -75,000 | -22% | -$536K |
|
8
Adicet Bio
ACET
$59.9M
| $1.85M | 3.32% | 2,456,194 -75,000 | -3% | -$56.6K |
|
|
BCYC
9
Bicycle Therapeutics
BCYC
$511M
| $1.46M | 2.61% | 171,695 -50,216 | -23% | -$426K |
|
10
Immatics
IMTX
$619M
| $1.38M | 2.47% | 304,902 -69,000 | -18% | -$311K |
|
11
Repare Therapeutics
RPTX
$71.7M
| $1.28M | 2.29% | 1,293,715 | – | – |
|
|
12
Zymeworks
ZYME
$1.12B
| $1.01M | 1.8% | +84,482 | New | +$1.01M |
|
13
Amgen
AMGN
$155B
| – | – | 0 | – | – |
|
|
SLN
14
Silence Therapeutics
SLN
$227M
| – | – | -367,214 | Closed | -$2.53M |
|
15
Sutro Biopharma
STRO
$72.7M
| – | – | -498 | Closed | -$916 |
|